Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes

Cancer vaccines may be harnessed to incite immunity against poorly immunogenic tumors, however they have failed in therapeutic settings. Poor antigenicity coupled with systemic and intratumoral immune suppression have been significant drawbacks. RNA encoding for tumor associated or specific epitopes...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayour, Elias J., Mendez-Gomez, Hector R., Mitchell, Duane A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213933/
https://www.ncbi.nlm.nih.gov/pubmed/30249040
http://dx.doi.org/10.3390/ijms19102890

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213933/
https://www.ncbi.nlm.nih.gov/pubmed/30249040
http://dx.doi.org/10.3390/ijms19102890

Ejemplares similares